The application value of Multimodal Ultrasound in the differential diagnosis of benign and malignant cervical lymph node lesions

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047446

Enrollment

Unknown

Registered

2021-06-18

Start date

2021-08-01

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical lymph node

Interventions

benign group vs. malignant group:No

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Adults over 18 years old; 2.Cervical lymph nodes enlargement; 3.Pathological diagnosis completed or imminent.

Exclusion criteria

Exclusion criteria: Abdication to ultrasound contrast agent.

Design outcomes

Primary

Measure	Time frame
ultrasound score;virtual touch tissue image quantification;contrast-enhanced ultrasound;	—

Countries

China

Contacts

Public ContactFang Lingyun

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

fangly@hust.edu.cn+86 18207177828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026